ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

July 11, 2014

NCI to Host SBIR Investor Forum

November 7, 2014

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

Program Announcement In Preventative Oncology

May 21, 1982

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990